Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
02:32pm, Saturday, 26'th Apr 2025
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in
Merck Stays Confident On M&A Despite Market Uncertainty: Analyst
03:54pm, Friday, 25'th Apr 2025
Merck & Co. Inc‘s MRK M&A efforts will continue.
Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut
03:20pm, Thursday, 24'th Apr 2025
MRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.
Germany's Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports
03:20pm, Thursday, 24'th Apr 2025
Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks
03:05pm, Thursday, 24'th Apr 2025
The two companies have been talking for months about a deal
Merck & Co., Inc. (MRK) Q1 2025 Earnings Call Transcript
02:01pm, Thursday, 24'th Apr 2025
Merck & Co., Inc. (NYSE:MRK ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Corporate Participants Peter Dannenbaum - Senior Vice President, Investor Relations Rob Davis - Chairman and Ch
Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM
01:10pm, Thursday, 24'th Apr 2025
The Investment Committee debate how to trade some stocks on the move today.
Merck (MRK) Reports Q1 Earnings: What Key Metrics Have to Say
11:30am, Thursday, 24'th Apr 2025
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street est
Merck lowers profit outlook due to expected $200M tariff hit
10:51am, Thursday, 24'th Apr 2025
Merck & Co Inc (NYSE:MRK, ETR:6MK) has lowered its full-year earnings forecast due to an expected $200 million hit from global tariffs, notably levies between the US and China. The company now expects
2 Blue-Chip Stocks Brushing Off Earnings Beats
10:45am, Thursday, 24'th Apr 2025
Pharmaceutical giant Merck & Co Inc (NYSE:MRK) has reversed its premarket lead, down 2% at $77.20 at last glance.
Cramer's Mad Dash: Merck
09:48am, Thursday, 24'th Apr 2025
Jim Cramer breaks down why he's keeping an eye on shares of Merck.
Merck absorbs $200 million in tariff costs into its earnings and full-year outlook
09:17am, Thursday, 24'th Apr 2025
Shares of Merck & Co. were headed higher in early Thursday trading, after the drugmaker extended its long streak of quarterly earnings beats and held firm with its full-year outlook despite expected t
Merck (MRK) Q1 Earnings and Revenues Top Estimates
08:40am, Thursday, 24'th Apr 2025
Merck (MRK) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.07 per share a year ago.
Merck Cuts 2025 View on Tariffs, Charges
07:09am, Thursday, 24'th Apr 2025
Merck's first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tarif
